{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:30:25Z","timestamp":1792639825788,"version":"4.5.0"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T00:00:00Z","timestamp":1638403200000},"content-version":"am","delay-in-days":335,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100002661","name":"Fonds De La Recherche Scientifique - FNRS","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002661","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.imbio.2020.152031","type":"journal-article","created":{"date-parts":[[2020,11,23]],"date-time":"2020-11-23T02:02:58Z","timestamp":1606096978000},"page":"152031","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function"],"prefix":"10.1016","volume":"226","author":[{"given":"Geraldine","family":"Dahlqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Renaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clement","family":"Barjon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda","family":"Aoudjehane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Horsmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadira","family":"Delhem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6673","key":"10.1016\/j.imbio.2020.152031_b0005","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.imbio.2020.152031_b0010","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1084\/jem.20082394","article-title":"Constitutive ablation of dendritic cells breaks self-tolerance of CD4 T cells and results in spontaneous fatal autoimmunity","volume":"206","author":"Ohnmacht","year":"2009","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.imbio.2020.152031_b0015","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.humimm.2017.10.017","article-title":"Regulatory dendritic cells for promotion of liver transplant operational tolerance: rationale for a clinical trial and accompanying mechanistic studies","volume":"79","author":"Thomson","year":"2018","journal-title":"Hum. Immunol."},{"issue":"8","key":"10.1016\/j.imbio.2020.152031_b0020","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1172\/JCI84577","article-title":"Donor dendritic cell-derived exosomes promote allograft-targeting immune response","volume":"126","author":"Liu","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.imbio.2020.152031_b0025","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.7164\/antibiotics.40.1256","article-title":"FK-506, a novel immunosuppressant isolated from a Streptomyces. II. Immunosuppressive effect of FK-506 in vitro","volume":"40","author":"Kino","year":"1987","journal-title":"J. Antibiot. (Tokyo)"},{"issue":"8670","key":"10.1016\/j.imbio.2020.152031_b0030","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(89)91014-3","article-title":"FK 506 for liver, kidney, and pancreas transplantation","volume":"2","author":"Starzl","year":"1989","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imbio.2020.152031_b0035","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.cmet.2014.01.001","article-title":"Rapamycin: one drug, many effects","volume":"19","author":"Li","year":"2014","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.imbio.2020.152031_b0040","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.immuni.2010.09.002","article-title":"The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism","volume":"33","author":"Powell","year":"2010","journal-title":"Immunity"},{"issue":"5","key":"10.1016\/j.imbio.2020.152031_b0045","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/S0889-8588(02)00051-5","article-title":"Clinical development of mammalian target of rapamycin inhibitors","volume":"16","author":"Dancey","year":"2002","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"10.1016\/j.imbio.2020.152031_b0050","article-title":"Immunosuppression withdrawal in liver transplant recipients on sirolimus","author":"Levitsky","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0055","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/nri1256","article-title":"Dendritic cells: emerging pharmacological targets of immunosuppressive drugs","volume":"4","author":"Hackstein","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"274","key":"10.1016\/j.imbio.2020.152031_b0060","article-title":"Tolerogenic dendritic cells in solid organ transplantation: where do we stand?","volume":"9","author":"Mar\u00edn","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.imbio.2020.152031_b0065","doi-asserted-by":"crossref","unstructured":"Naranjo-G\u00f3mez, M., Ra\u00efch-Regu\u00e9, D., O\u00f1ate, C., et al., Comparative study of clinical grade human tolerogenic dendritic cells. J. Transl. Med. 2011;9:89-89.","DOI":"10.1186\/1479-5876-9-89"},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0070","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.imlet.2007.11.013","article-title":"GMCSF in the absence of other cytokines sustains human dendritic cell precursors with T cell regulatory activity and capacity to differentiate into functional dendritic cells","volume":"116","author":"Chitta","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imbio.2020.152031_b0075","doi-asserted-by":"crossref","unstructured":"Moreau, A., Varey, E., Bouchet-Delbos, L., Cuturi, M.-C., Cell therapy using tolerogenic dendritic cells in transplantation. Transplant. Res. 2012;1(1):13-13.","DOI":"10.1186\/2047-1440-1-13"},{"issue":"7","key":"10.1016\/j.imbio.2020.152031_b0080","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3349\/ymj.2018.59.7.807","article-title":"Generation, characteristics and clinical trials of ex vivo generated tolerogenic dendritic cells","volume":"59","author":"Kim","year":"2018","journal-title":"Yonsei Med. J."},{"key":"10.1016\/j.imbio.2020.152031_b0085","doi-asserted-by":"crossref","unstructured":"Raker, V.K., Domogalla, M.P., Steinbrink, K., Tolerogenic dendritic cells for regulatory T cell induction in man. Front. Immunol., 2015;6:569-569.","DOI":"10.3389\/fimmu.2015.00569"},{"key":"10.1016\/j.imbio.2020.152031_b0090","doi-asserted-by":"crossref","unstructured":"Navarro-Barriuso, J., Mansilla, M.J., Naranjo-G\u00f3mez, M., et al., Comparative transcriptomic profile of tolerogenic dendritic cells differentiated with vitamin D3, dexamethasone and rapamycin. Sci. Rep., 2018;8(1):14985-14985.","DOI":"10.1038\/s41598-018-33248-7"},{"key":"10.1016\/j.imbio.2020.152031_b0095","doi-asserted-by":"crossref","unstructured":"Orange, D.E., Blachere, N.E., Fak, J., et al. Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo. Elife. 2013;2:e00105-e00105.","DOI":"10.7554\/eLife.00105"},{"issue":"12","key":"10.1016\/j.imbio.2020.152031_b0100","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.molimm.2005.01.006","article-title":"Immunosuppressive agents mediate reduced allostimulatory properties of myeloid-derived dendritic cells despite induction of divergent molecular phenotypes","volume":"42","author":"Duperrier","year":"2005","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0105","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0110","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1182\/blood.V98.1.174","article-title":"Rapamycin induces apoptosis in monocyte- and CD34-derived dendritic cells but not in monocytes and macrophages","volume":"98","author":"Woltman","year":"2001","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0115","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007890-200301150-00025","article-title":"Rapamycin impairs antigen uptake of human dendritic cells","volume":"75","author":"Monti","year":"2003","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.imbio.2020.152031_b0120","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1038\/nri1457","article-title":"Ido expression by dendritic cells: tolerance and tryptophan catabolism","volume":"4","author":"Mellor","year":"2004","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.imbio.2020.152031_b0125","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.3892\/mmr.2015.3713","article-title":"Impact of immunosuppressive agents on the expression of indoleamine 2,3-dioxygenase, heme oxygenase-1 and interleukin-7 in mesangial cells","volume":"12","author":"Liang","year":"2015","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.imbio.2020.152031_b0130","doi-asserted-by":"crossref","unstructured":"Mellor, A.L., Lemos, H., Huang, L., Indoleamine 2,3-Dioxygenase and Tolerance: Where Are We Now? Front. Immunol. 2017;8:1360-1360.","DOI":"10.3389\/fimmu.2017.01360"},{"issue":"5","key":"10.1016\/j.imbio.2020.152031_b0135","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.humimm.2017.10.007","article-title":"Tolerance in clinical liver transplantation","volume":"79","author":"Levitsky","year":"2018","journal-title":"Hum. Immunol."},{"issue":"S1","key":"10.1016\/j.imbio.2020.152031_b0140","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/lt.24620","article-title":"Strategies for minimizing immunosuppression: state of the art","volume":"22","author":"Sanchez-Fueyo","year":"2016","journal-title":"Liver Transpl."},{"issue":"7","key":"10.1016\/j.imbio.2020.152031_b0145","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.4049\/jimmunol.1000296","article-title":"A versatile role of mammalian target of rapamycin in human dendritic cell function and differentiation","volume":"185","author":"Haidinger","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.imbio.2020.152031_b0150","doi-asserted-by":"crossref","unstructured":"He, Z., Zhu, X., Shi, Z., Wu, T., Wu, L., Metabolic Regulation of Dendritic Cell Differentiation. Front Immunol. 2019;10:410-410.","DOI":"10.3389\/fimmu.2019.00410"},{"issue":"8","key":"10.1016\/j.imbio.2020.152031_b0155","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1016\/j.transproceed.2009.08.043","article-title":"Inhibitory effects of cyclosporine on human regulatory T cells in vitro","volume":"41","author":"Miroux","year":"2009","journal-title":"Transplant Proc."},{"issue":"2","key":"10.1016\/j.imbio.2020.152031_b0160","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/TP.0b013e3182590d8f","article-title":"In vitro effects of cyclosporine A and tacrolimus on regulatory T-cell proliferation and function","volume":"94","author":"Miroux","year":"2012","journal-title":"Transplantation"},{"issue":"9","key":"10.1016\/j.imbio.2020.152031_b0165","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1016\/j.transproceed.2012.09.091","article-title":"Corticosteroids do not reverse the inhibitory effect of cyclosporine on regulatory T-cell activity in contrast to mycophenolate mofetil","volume":"44","author":"Miroux","year":"2012","journal-title":"Transplant Proc."},{"issue":"3","key":"10.1016\/j.imbio.2020.152031_b0170","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/ndt\/gfp586","article-title":"Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs","volume":"25","author":"Bocian","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"issue":"2","key":"10.1016\/j.imbio.2020.152031_b0175","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1097\/TP.0b013e318200e97","article-title":"Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction","volume":"91","author":"Levitsky","year":"2011","journal-title":"Transplantation"},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0180","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2007-06-094482","article-title":"Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells","volume":"111","author":"Zeiser","year":"2008","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.imbio.2020.152031_b0185","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1600-6143.2004.00673.x","article-title":"Rapamycin-treated, alloantigen-pulsed host dendritic cells induce Ag-specific T cell regulation and prolong graft survival","volume":"5","author":"Taner","year":"2005","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.imbio.2020.152031_b0190","doi-asserted-by":"crossref","unstructured":"Macedo, C., Turquist, H., Metes, D., Thomson, A.W., Immunoregulatory properties of rapamycin-conditioned monocyte-derived dendritic cells and their role in transplantation. Transplant. Res., 2012;1(1):16-16.","DOI":"10.1186\/2047-1440-1-16"},{"issue":"11","key":"10.1016\/j.imbio.2020.152031_b0195","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1111\/j.1600-6143.2012.04212.x","article-title":"Everolimus with reduced tacrolimus improves renal function in de novo liver transplant recipients: a randomized controlled trial","volume":"12","author":"De Simone","year":"2012","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.imbio.2020.152031_b0200","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1182\/blood-2004-10-3932","article-title":"Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells","volume":"105","author":"Battaglia","year":"2005","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0205","first-page":"106","article-title":"Functional differentiation of human cytotoxic T lymphocytes in the presence of FK 506 and CyA","volume":"22","author":"Zeevi","year":"1990","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.imbio.2020.152031_b0210","doi-asserted-by":"crossref","unstructured":"Hubo, M., Trinschek, B., Kryczanowsky, F., Tuettenberg, A., Steinbrink, K., Jonuleit, H., Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front. Immunol. 2013;4:82-82.","DOI":"10.3389\/fimmu.2013.00082"},{"issue":"3","key":"10.1016\/j.imbio.2020.152031_b0215","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/ndt\/gfg594","article-title":"In vitro treatment of dendritic cells with tacrolimus: impaired T-cell activation and IP-10 expression","volume":"19","author":"Tiefenthaler","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0220","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bbrc.2018.10.183","article-title":"IL-10 gene-modified dendritic cells-induced type 1 T regulatory cells inhibit graft-versus-host disease while preserving graft-versus-leukemia effect","volume":"507","author":"Wan","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6","key":"10.1016\/j.imbio.2020.152031_b0225","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1182\/blood-2009-07-234872","article-title":"Differentiation of type 1 T regulatory cells (Tr1) by tolerogenic DC-10 requires the IL-10\u2013dependent ILT4\/HLA-G pathway","volume":"116","author":"Gregori","year":"2010","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.imbio.2020.152031_b0230","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.0902133","article-title":"Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific energy and regulatory properties in memory CD4+ T cells","volume":"184","author":"Torres-Aguilar","year":"2010","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00430-011-0202-5","article-title":"mTOR signaling pathway regulates the IL-12\/IL-10 axis in Leishmania donovani infection","volume":"201","author":"Cheekatla","year":"2012","journal-title":"Med. Microbiol. Immunol."},{"issue":"11\u201312","key":"10.1016\/j.imbio.2020.152031_b0240","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1016\/j.molimm.2009.04.011","article-title":"Rapamycin enhances LPS induction of tissue factor and tumor necrosis factor-alpha expression in macrophages by reducing IL-10 expression","volume":"46","author":"Baker","year":"2009","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0245","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.intimp.2014.05.004","article-title":"Tolerogenic dendritic cells modified by tacrolimus suppress CD4+ T-cell proliferation and inhibit collagen-induced arthritis in mice","volume":"21","author":"Ren","year":"2014","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.imbio.2020.152031_b0250","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1038\/ni.2077","article-title":"Indoleamine 2,3-dioxygenase is a signaling protein in long-term tolerance by dendritic cells","volume":"12","author":"Pallotta","year":"2011","journal-title":"Nat. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0255","doi-asserted-by":"crossref","first-page":"130","DOI":"10.4049\/jimmunol.177.1.130","article-title":"Kynurenine pathway enzymes in dendritic cells initiate tolerogenesis in the absence of functional IDO","volume":"177","author":"Belladonna","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0260","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.0803277","article-title":"Tryptophan deprivation induces inhibitory receptors ILT3 and ILT4 on dendritic cells favoring the induction of human CD4+CD25+ Foxp3+ T regulatory cells","volume":"183","author":"Brenk","year":"2009","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2020.152031_b0265","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/gt.2016.59","article-title":"Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction","volume":"23","author":"Vavrincova-Yaghi","year":"2016","journal-title":"Gene Ther."},{"issue":"14","key":"10.1016\/j.imbio.2020.152031_b0270","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/bloodadvances.2017006858","article-title":"Novel GM-CSF signals via IFN-\u03b3R\/IRF-1 and AKT\/mTOR license monocytes for suppressor function","volume":"1","author":"Ribechini","year":"2017","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.imbio.2020.152031_b0275","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1038\/sj.mp.4002148","article-title":"Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice","volume":"14","author":"O'Connor","year":"2009","journal-title":"Mol. Psychiatry"},{"issue":"1","key":"10.1016\/j.imbio.2020.152031_b0280","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1177\/1753425913481252","article-title":"Activation of indoleamine 2,3-dioxygenase by LPS in a porcine model","volume":"20","author":"Wirthgen","year":"2014","journal-title":"Innate Immun."},{"key":"10.1016\/j.imbio.2020.152031_b0285","article-title":"Dendritic cells treated with exogenous indoleamine 2,3-dioxygenase maintain an immature phenotype and suppress antigen-specific T cell proliferation","volume":"5","author":"Bracho-Sanchez","year":"2019","journal-title":"J. Immunol. Regen. Med."},{"issue":"4","key":"10.1016\/j.imbio.2020.152031_b0290","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/eji.201343862","article-title":"Regulation of the tolerogenic function of steady-state DCs","volume":"44","author":"Probst","year":"2014","journal-title":"Eur. J. Immunol."},{"issue":"11","key":"10.1016\/j.imbio.2020.152031_b0295","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.imbio.2020.152031_b0300","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/ajt.12351","article-title":"Rapamycin augments human DC IL-12p70 and IL-27 secretion to promote allogeneic Type 1 polarization modulated by NK cells","volume":"13","author":"Macedo","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"5","key":"10.1016\/j.imbio.2020.152031_b0305","doi-asserted-by":"crossref","first-page":"622","DOI":"10.4161\/cbt.7.5.5689","article-title":"Clinical significance of B7\u2013H1(PD-L1)expression in human acute leukemia","volume":"7","author":"Chen","year":"2008","journal-title":"Cancer Biol. Ther."},{"issue":"4","key":"10.1016\/j.imbio.2020.152031_b0310","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520305532?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298520305532?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T16:47:16Z","timestamp":1759250836000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298520305532"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S0171298520305532"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152031","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modulatory effect of rapamycin and tacrolimus on monocyte-derived dendritic cells phenotype and function","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2020.152031","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152031"}}